Prophylactic Supplementation of Omega-3 Polyunsaturated Fatty Acids Attenuates White Matter Injury a

来源 :上海市科学技术协会第十届学术年会——长三角地区神经科学论坛2012 | 被引量 : 0次 | 上传用户:liyunfeng890406
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Traumatic Brain Injury (TBI) is a neurological disorder that leads to short and possibly long term motor and cognitive dysfunction with no effective therapeutic agent to date.Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been reported to attenuate motor and cognitive deficits resulting from ischemic injury that shares similar cell death mechanisms with TBI.In this study, we investigated the long term neuroprotectiive effects of prophylactic supplementation of n-3 PUFAs against TBI using a controlled cortical impact (CCI) mouse model.Our results showed that the inclusion of n-3 PUFAs in the diet for 2 months before TBI and during the entire course of study attenuated short and long term (up to 35 days after TBI) motor deficits as determined using hang wire, cylinder and foot fault tests.Supplementation of n-3 PUFAs also significantly improved cognitive performance of TBI mice in the Morris water maze tests 22-27 days post-TBI.
其他文献
会议
会议
会议
会议
会议
会议
会议
Mutations in the glucocerebrosidase gene (GBA) are associated with Gauchers disease, the lysosomal storage disease.Recent studies indicate that pathological variants in GBA have increased the risk for
会议
会议
目的:左旋多巴(LD)迄今仍是治疗帕金森病的首选药物,但由于副作用明显,大大限制了其临床应用。因此利用新型技术制备LD长效缓释制剂,既明显提高血脑屏障通透性,又避免外周脱羧,仅需要运用微小剂量的LD,即可达到治疗目的,从而显著减少LD所引起不良反应的发生率。载药纳米微粒是纳米技术与现代医药学结合的产物,是一种药物控释和缓释的新剂型。直径在10~500nm之间,为固状胶态粒子,通过包裹、吸附、或者附
会议